全文获取类型
收费全文 | 42篇 |
免费 | 1篇 |
专业分类
化学 | 27篇 |
力学 | 1篇 |
数学 | 2篇 |
物理学 | 13篇 |
出版年
2022年 | 3篇 |
2021年 | 1篇 |
2020年 | 2篇 |
2016年 | 2篇 |
2015年 | 1篇 |
2013年 | 5篇 |
2012年 | 1篇 |
2011年 | 4篇 |
2008年 | 1篇 |
2007年 | 1篇 |
2006年 | 1篇 |
2004年 | 1篇 |
2002年 | 1篇 |
1998年 | 1篇 |
1987年 | 1篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1976年 | 1篇 |
1975年 | 1篇 |
1967年 | 1篇 |
1966年 | 1篇 |
1941年 | 1篇 |
1918年 | 1篇 |
1899年 | 1篇 |
1897年 | 2篇 |
1894年 | 1篇 |
1890年 | 1篇 |
1888年 | 3篇 |
1885年 | 1篇 |
排序方式: 共有43条查询结果,搜索用时 15 毫秒
41.
42.
Yen-Ru Huang Jing-Ru Huang Yi-Min Chen Ying-Sheng Huang Gerd Keiser San-Liang Lee Kuei-Yi Lee 《Solid State Communications》2011,151(14-15):1022-1024
To achieve the maximum area utilization ratio for a parallel electrode capacitor, an Archimedean spiral was used to design the capacitor pattern. Multi-walled vertically aligned carbon nanotubes (VACNTs) were used for the capacitor electrodes because of their metallic properties and their endurance toward various chemical reagents. In contrast to the parallel plate capacitor, the total capacitance was formed by parallel connections of all unit cells of the individual VACNT capacitors, so that a relatively higher capacitance was obtained. This design can provide a new approach to fill diverse dielectrics into a spiral capacitor to obtain different capacitances for various applications. 相似文献
43.
Christoph Wenzel Lisa Gdtke Anne Reichstein Markus Keiser Diana Busch Marek Drozdzik Stefan Oswald 《Molecules (Basel, Switzerland)》2022,27(14)
Background: Unwanted drug-drug interactions (DDIs), as caused by the upregulation of clinically relevant drug metabolizing enzymes and transporter proteins in intestine and liver, have the potential to threaten the therapeutic efficacy and safety of drugs. The molecular mechanism of this undesired but frequently occurring scenario of polypharmacy is based on the activation of nuclear receptors such as the pregnane X receptor (PXR) or the constitutive androstane receptor (CAR) by perpetrator agents such as rifampin, phenytoin or St. John’s wort. However, the expression pattern of nuclear receptors in human intestine and liver remains uncertain, which makes it difficult to predict the extent of potential DDIs. Thus, it was the aim of this study to characterize the gene expression and protein abundance of clinically relevant nuclear receptors, i.e., the aryl hydrocarbon receptor (AhR), CAR, farnesoid X receptor (FXR), glucocorticoid receptor (GR), hepatocyte nuclear factor 4 alpha (HNF4α), PXR and small heterodimer partner (SHP), in the aforementioned organs. Methods: Gene expression analysis was performed by quantitative real-time PCR of jejunal, ileal, colonic and liver samples from eight human subjects. In parallel, a targeted proteomic method was developed and validated in order to determine the respective protein amounts of nuclear receptors in human intestinal and liver samples. The LC-MS/MS method was validated according to the current bioanalytical guidelines and met the criteria regarding linearity (0.1–50 nmol/L), within-day and between-day accuracy and precision, as well as the stability criteria. Results: The developed method was successfully validated and applied to determine the abundance of nuclear receptors in human intestinal and liver samples. Gene expression and protein abundance data demonstrated marked differences in human intestine and liver. On the protein level, only AhR and HNF4α could be detected in gut and liver, which corresponds to their highest gene expression. In transfected cell lines, PXR and CAR could be quantified. Conclusions: The substantially different expression pattern of nuclear receptors in human intestinal and liver tissue may explain the different extent of unwanted DDIs in the dependence on the administration route of drugs. 相似文献